Legal & General Group
CTKB icon

Legal & General Group’s Cytek Biosciences CTKB Stock Holding History

Legal & General Group’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.3K Sell
11,810
-171,050
-94% -$730K ﹤0.01% 2749
2026
Q1 		$799K Sell
182,860
-5,608
-3% -$26.5K ﹤0.01% 2212
2025
Q4 		$952K Sell
188,468
-3,907
-2% -$18.1K ﹤0.01% 2231
2025
Q3 		$668K Sell
192,375
-117,916
-38% -$443K ﹤0.01% 2360
2025
Q2 		$1.05M Buy
310,291
+13,462
+5% +$44.9K ﹤0.01% 2222
2025
Q1 		$1.19M Sell
296,829
-16,208
-5% -$84K ﹤0.01% 2121
2024
Q4 		$2.03M Buy
313,037
+20,699
+7% +$123K ﹤0.01% 1975
2024
Q3 		$1.62M Buy
292,338
+12,863
+5% +$72.9K ﹤0.01% 2057
2024
Q2 		$1.56M Sell
279,475
-8,191
-3% -$49.2K ﹤0.01% 2054
2024
Q1 		$1.93M Sell
287,666
-1,100
-0.4% -$8.7K ﹤0.01% 1958
2023
Q4 		$2.63M Buy
288,766
+9,655
+3% +$60.8K ﹤0.01% 1809
2023
Q3 		$1.54M Buy
279,111
+47,532
+21% +$381K ﹤0.01% 2010
2023
Q2 		$1.98M Buy
231,579
+194,270
+521% +$1.74M ﹤0.01% 1936
2023
Q1 		$343K Buy
37,309
+1,429
+4% +$15.4K ﹤0.01% 2423
2022
Q4 		$366K Buy
35,880
+425
+1% +$5.71K ﹤0.01% 2415
2022
Q3 		$522K Sell
35,455
-4,199
-11% -$54.5K ﹤0.01% 2333
2022
Q2 		$425K Buy
39,654
+29,802
+302% +$297K ﹤0.01% 2381
2022
Q1 		$106K Buy
9,852
+8,252
+516% +$111K ﹤0.01% 2849
2021
Q4 		$26K Hold
1,600
– – ﹤0.01% 3190
2021
Q3 		$34K Buy
+1,600
New +$37.6K ﹤0.01% 3082

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Legal & General Group's CTKB Position: Q2 2026 in Review

Legal & General Group reduced its Cytek Biosciences (CTKB) stake by 94% in Q2 2026, selling an estimated $730K and leaving 11,810 shares worth $52.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2749.

Legal & General Group first reported a position in CTKB in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.63M in Q4 2023. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Legal & General Group held 11,810 shares of Cytek Biosciences worth $52.3K as of Q2 2026.
  • Legal & General Group sold 171,050 Cytek Biosciences shares in Q2 2026, an estimated $730K.
  • Cytek Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2749 holding.
  • Legal & General Group first reported a position in Cytek Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Legal & General Group's Cytek Biosciences position peaked at $2.63M in Q4 2023.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.